A new class of drug for pulmonary arterial hypertension. Can a Rho-kinase inhibitor break the stagnation in treating it? - Suppr | 超能文献

A new class of drug for pulmonary arterial hypertension. Can a Rho-kinase inhibitor break the stagnation in treating it?

作者信息

Miyagawa Kazuya, Emoto Noriaki

机构信息

Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine.

出版信息

Circ J. 2013;77(10):2477-8. doi: 10.1253/circj.cj-13-0951. Epub 2013 Aug 9.

DOI:10.1253/circj.cj-13-0951

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A new class of drug for pulmonary arterial hypertension. Can a Rho-kinase inhibitor break the stagnation in treating it?

Circ J. 2013;77(10):2477-8. doi: 10.1253/circj.cj-13-0951. Epub 2013 Aug 9.

2

Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension.一项 rho 激酶抑制剂治疗肺动脉高压的双盲、安慰剂对照临床试验。

Circ J. 2013;77(10):2619-25. doi: 10.1253/circj.cj-13-0443. Epub 2013 Aug 3.

3

Effects of the Rho-kinase inhibitor, fasudil, on pulmonary hypertension.Rho激酶抑制剂法舒地尔对肺动脉高压的影响。

Circ J. 2015;79(6):1213-4. doi: 10.1253/circj.CJ-15-0443. Epub 2015 Apr 30.

4

Super-selective intracoronary injection of Rho-kinase inhibitor relieves refractory coronary vasospasms: a case report.

Int J Cardiol. 2014 Sep;176(1):270-1. doi: 10.1016/j.ijcard.2014.06.096. Epub 2014 Jul 8.

5

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension.Rho激酶抑制剂法舒地尔对重度肺动脉高压患者的急性血管舒张作用

Heart. 2005 Mar;91(3):391-2. doi: 10.1136/hrt.2003.029470.

6

Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.同时抑制 rho 激酶和酪氨酸激酶血小板衍生生长因子在实验性肺动脉高压中的作用。

Pharmacology. 2014;93(3-4):145-50. doi: 10.1159/000360182. Epub 2014 Mar 18.

7

[Effects of intervention with Rho kinase inhibitor fasudil on rats with hypoxic pulmonary hypertension].Rho激酶抑制剂法舒地尔干预对缺氧性肺动脉高压大鼠的影响

Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):946-7.

8

Influence of Rho kinase inhibitor fasudil on late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension.Rho激酶抑制剂法舒地尔对慢性阻塞性肺疾病合并肺动脉高压患者外周血晚期内皮祖细胞的影响

Bratisl Lek Listy. 2015;116(3):150-3. doi: 10.4149/bll_2015_030.

9

Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease.急性抑制Rho激酶可减轻先天性心脏病患者的肺动脉高压。

Pediatr Cardiol. 2009 Apr;30(3):363-6. doi: 10.1007/s00246-008-9315-z. Epub 2008 Oct 25.

10

The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.法舒地尔和西地那非对野百合碱诱导的大鼠肺动脉高压的有益影响：一项血流动力学和生化研究。

Pharmacology. 2013;91(3-4):178-84. doi: 10.1159/000346921. Epub 2013 Feb 21.

引用本文的文献

1

Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension.肺动脉高压患者肺组织的磷酸化蛋白质组学分析

Pulm Circ. 2021 Aug 19;11(3):20458940211031109. doi: 10.1177/20458940211031109. eCollection 2021 Jul-Sep.